[Skip to Navigation]
May 2014

Why Does Antimicrobial Overuse in Hospitalized Patients Persist?

Author Affiliations
  • 1Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan
  • 2Department of Medicine, University of Michigan Medical School, Ann Arbor
JAMA Intern Med. 2014;174(5):661-662. doi:10.1001/jamainternmed.2014.897

God gave the world to men in common; but since he gave it to them for their own benefit…it cannot be supposed he meant it should always remain common….

John Locke, Second Treatise of Government, 1689

…you are undone if you once forget that the fruits of the earth belong to us all, and the earth itself to nobody.

Jean-Jacques Rousseau, Discourse on Inequality, 1754

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Biofilms and Susceptibility tests
    James G Timourian | Innovotech Inc.
    If the right antimicrobial product was selected the first time, organisms would have less ability to develope resistance. Many infections involve bacteria in a difficult to kill biofilm state. There are susceptibility tests that are approved in Canada that test antibiotics against specific biofilms. There also is a standard device (the MBEC Assay) that can be used to grow biofilms and test antimicrobials for effectiveness. If these tests were in wider use they would cut down the excessive use of antimicrobial products in hospitals.
    CONFLICT OF INTEREST: James Timourian is a shareholder in and the President of Innovotech Inc., whose products are directly related to the comment.